Clinical Trials Insight: 700028631
Phase of Trial: Phase II
Latest Information Update: 28 Mar 2008
At a glance
- Drugs Lapaquistat (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors Takeda
- 28 Mar 2008 Status changed from in progress to discontinued. According to a Takeda media release, development of lapaquistat is being discontinued.
- 20 Nov 2007 New trial record.